Medicine and Dentistry
Amphotericin B
100%
Micafungin
100%
Lung
66%
Monotherapy
66%
Invasive Aspergillosis
66%
Combination Therapy
50%
Therapeutic Procedure
33%
Serum
33%
Survival
33%
Spleen
33%
Kidney
16%
Female
16%
Histopathology
16%
Intraperitoneal Drug Administration
16%
Cyclophosphamide
16%
Combined Therapy
16%
Immunosuppressive Drug
16%
Pyrrole Derivative
16%
Antifungal Agent
16%
Aspergillus
16%
Galactomannan
16%
Aspergillus fumigatus
16%
Echinocandin
16%
Polyene
16%
Pharmacology, Toxicology and Pharmaceutical Science
Amphotericin B
100%
Micafungin
100%
Monotherapy
66%
Invasive Aspergillosis
66%
Combination Therapy
50%
Mouse
50%
Survival
33%
Mouse Model
33%
Cyclophosphamide
16%
Fungus
16%
Immunosuppressive Agent
16%
Intraperitoneal Injection
16%
Institute for Cancer Research Mouse
16%
Pyrrole Derivative
16%
Aspergillus
16%
Galactomannan
16%
Polyene
16%
Conidium
16%
Echinocandin
16%
Aspergillus fumigatus
16%
Biochemistry, Genetics and Molecular Biology
Micafungin
100%
Mouse
50%
Survival
33%
Experiment
16%
Fungus
16%
Inoculation
16%
Cyclophosphamide
16%
Institute for Cancer Research Mouse
16%
Aspergillus fumigatus
16%
Conidium
16%
Galactomannan
16%
Echinocandin
16%
Immunology and Microbiology
Lung
66%
Mouse
50%
Survival
33%
Mouse Model
33%
Experiment
16%
Fungus
16%
Conidium
16%
Kidney
16%
Cyclophosphamide
16%
Immunosuppressive Drug
16%
Institute for Cancer Research Mouse
16%
Aspergillus
16%
Aspergillus fumigatus
16%